Skip to main navigation Skip to search Skip to main content

Predictive prioritization of enhancers associated with pancreatic disease risk

  • Li Wang
  • , Songjoon Baek
  • , Gauri Prasad
  • , John Wildenthal
  • , Konnie Guo
  • , David Sturgill
  • , Thucnhi Truongvo
  • , Erin Char
  • , Gianluca Pegoraro
  • , Katherine McKinnon
  • , Jun Zhong
  • , Demetrius Albanes
  • , Gabriella Andreotti
  • , Alan A. Arslan
  • , Laura Beane-Freeman
  • , Sonja I. Berndt
  • , Julie E. Buring
  • , Daniele Campa
  • , Federico Canzian
  • , Stephen J. Chanock
  • Yu Chen, Sandra M. Colorado-Yohar, A. Heather Eliassen, J. Michael Gaziano, Graham G. Giles, Phyllis J. Goodman, Christopher A. Haiman, Mattias Johansson, Verena Katzke, Charles Kooperberg, Peter Kraft, Manolis Kogevinas, I. Min Lee, Loic LeMarchand, Núria Malats, Satu Männistö, Marjorie L. McCullough, Roger Milne, Stephen C. Moore, Lorelei Mucci, Salvatore Panico, Alpa V. Patel, Ulrike Peters, Miquel Porta, Francisco X. Real, Howard D. Sesso, Xiao Ou Shu, Meir J. Stampfer, Geoffrey S. Tobias, Kala Visvanathan, Elisabete Weiderpass, Nicolas Wentzensen, Emily White, Chen Yuan, Wei Zheng, Jean Wactawski-Wende, Rachael Z. Stolzenberg-Solomon, Brian M. Wolpin, Laufey T. Amundadottir, Samuel O. Antwi, Paige M. Bracci, Steven Gallinger, Michael Goggins, Manal Hassan, Elizabeth A. Holly, Rayjean J. Hung, Donghui Li, Núria Malats, Rachel E. Neale, Kari G. Rabe, Harvey A. Risch, Herbert Yu, Alison P. Klein, Jason W. Hoskins, Laufey T. Amundadottir, H. Efsun Arda
  • National Institutes of Health

Research output: Contribution to journalArticlepeer-review

Abstract

Genetic and epigenetic variation in enhancers is associated with disease susceptibility; however, linking enhancers to target genes and predicting enhancer dysfunction remain challenging. We mapped enhancer-promoter interactions in human pancreas using 3D chromatin assays across 28 donors and five cell types. Using a network approach, we parsed these interactions into enhancer-promoter tree models, enabling quantitative, genome-wide analysis of enhancer connectivity. A machine learning algorithm built on these trees estimated enhancer contributions to cell-type-specific gene expression. To test predictions, we perturbed enhancers in primary human pancreas cells with CRISPR interference and quantified effects at single-cell resolution using RNA fluorescence in situ hybridization (FISH) and high-throughput imaging. Tree models also annotated germline risk variants linked to pancreatic disorders, connecting them to candidate target genes. For pancreatic ductal adenocarcinoma risk, acinar regulatory elements showed greater variant enrichment, challenging the ductal cell-of-origin view. Together, these datasets and models provide a resource for studying pancreatic disease genetics.

Original languageEnglish
Article number101040
JournalCell Genomics
Volume6
Issue number1
DOIs
StatePublished - Jan 14 2026

Keywords

  • 3D genome organization
  • CRISPR
  • GWAS
  • cell identity
  • diabetes
  • enhancer
  • graph models
  • noncoding variants
  • pancreas
  • pancreatic cancer

Fingerprint

Dive into the research topics of 'Predictive prioritization of enhancers associated with pancreatic disease risk'. Together they form a unique fingerprint.

Cite this